21
Views
2
CrossRef citations to date
0
Altmetric
Original Paper

Tetanus Antitoxin Seroprevalence in Patients with Behçet's Disease

, , , , &
Pages 299-301 | Received 20 Jan 2003, Accepted 08 Apr 2003, Published online: 08 Jul 2009

References

  • Turan B, Gallati H, Erdi H, Gürler A, Michel BA, Villiger PM. Systemic levels of T cell regulatory cytokines IL-10 and IL-12 in Behcet’s disease, soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 1997; 24: 128–32.
  • Önder M, Gürer MA. The multiple faces of Behçet’s disease and its aetiological factors. J Eur Acad Dermatol 2001; 15: 126–36.
  • Esin S, Gül A, Hodara V, Jeddi-Tehrani M, Dilsen N, Koniçe M, Andersson R. Peripheral blood T cell expansions in patients with Behcet’s disease. Clin Exp Immunol 1997; 107: 520–7.
  • Sayinalp N, Özcebe OI, Özdemir O, Haznedaroglu IC, Dündar S, Kirazlı S. Cytokines in Behçet’s disease. J Rheumatol 1996; 23: 321–2.
  • Jorizzo JL. Behçet’s disease. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, eds. Dermatology in general medicine, 5th edn. New York: McGraw-Hill; 2000. p. 2161–5.
  • International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet 1990; 335: 1078–80.
  • Maple PAC, Jones CS, Wall EC, Vyse A, Edmunds WJ, Andrews NJ, Miller E. Immunity to diphtheria and tetanus in England and Wales. Vaccine 2001; 19: 167–73.
  • Krüger S, Seyfarth M, Sack K, Kreft B. Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination. Vaccine 1999; 17: 1145–50.
  • Sakane T, Suzuki N, Nagafuchi H. Etiopathology of Behçet’s disease: immunological aspects. Yonsei Med J 1997; 38: 350–8.
  • Stark K, Günther M, Schönfeld C, Tullius SG, Bienzie U. Immunisations in solid organ transplant recipients. Lancet 2002; 359: 957–65.
  • Dieye TN, Sow PS, Simonart T, Gueye-Ndiaye A, Popper SJ, Delforge M-L, et al. Immunologic and virologic response after tetanus toxoid booster among HIV-1 and HIV-2-infected Senegalese individuals. Vaccine 2002; 20: 905–13.
  • Mayer S, Laumer M, Mackensen A, Andreesen R, Krause SW. Analysis of the immune response against tetanus toxoid: enumeration of specific T helper cells by the Elispot assay. Immunology 2002; 205: 282–9.
  • Ergönul E, Sözen T, Tekeli E. Immunity to tetanus among adults in Turkey. Scand J Infect Dis 2001; 33: 728–30.
  • Laroche P, Barrand M, Wood SC, Van Hasbrouck K, Lang J, Harzer E, Hessel L. The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV). Infection 1999; 27: 53–60.
  • Sehgal R. Tetanus toxoid for adults. Lancet 1997; 349: 573.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.